BDD

BDD is at the forefront of pharmaceutical manufacturing, redefining early-stage development with its comprehensive drug delivery expertise and clinical capabilities. BDD accelerates product development pipelines, enables life cycle management, and creates new value-added products for its clientele. The company's rapid parallel clinical testing with BDD SWIFT significantly reduces the time from product concept to clinical success.

Located at Basement Medical Block, Within Glasgow Royal Infirmary, 84 Castle Street, Glasgow G4 0SF, GB, BDD specializes in providing responsive, flexible, and innovative solutions, understanding that a one-size-fits-all approach is insufficient in today's market. The company’s patented delayed-release technology, OralogiK, provides unparalleled control of drug release, ensuring precise delivery at the right place and time.

BDD's clinical division offers a full clinical package, including protocol development, study documentation design, regulatory authority submission, close-out, and production of ICH GCP-compliant clinical study reports. Specializing in gamma scintigraphy, a powerful technology, BDD investigates the in-vivo behavior of formulations. Coupled with pharmacokinetic data, this technique provides critical insights into the time and site of disintegration, gastric emptying, GI transit, and intra/inter-individual differences. We encourage the management team at BDD to create a customized and exclusive company showcase and product listing on our platform to further enhance your company's visibility.